Background Tumor-induced osteomalacia (TIO) is a rare condition with fewer than 500 cases reported in the literature although described. Phosphaturic mesenchymal tumor (PMT) is often unrecognized cause of hypophosphatemia. This case report aims to highlight such a rare association which warrants clinical and radiologist attention. Case A 51-year-old man had pain in his feet 2 years prior to the most recent presentation in our clinic. The patient experienced increasingly severe body aches and pain, which affected the feet, hips, knees, ribs, waist, and shoulders. MRI and CT led to the diagnosis of multiple insufficiency fractures. Laboratory tests showed that inorganic phosphate (IP) levels had decreased to 0.52 mmol/L(0.81–1.45 mmol/L), while alkaline phosphatase (ALP) had increased to 216 U/L(38.0–126.0 U/L). Positron emission tomography computed tomography showed tumor-derived hypophosphate osteomalacia of the right iliac wing; surgical resection was performed. markers of bone metabolism and bone density returned normal postoperative, after 9 months follow-up. Conclusion The possibility of tumor-induced osteomalacia should be considered if unexplained joint pain, decreased bone mineral density, increased ALP and insufficiency fractures, and no similar family history are found in adult patients. Surgical resection of the tumor is the key to the treatment.

No abstract

Purpose: This study was performed to explore the value of multi-modality technology, with a combination of narrow acquisition window, isocentric scanning, low tube voltage, low tube current and iterative reconstruction (IR), for reducing the radiation dose in multi-slice spiral computed tomography coronary angiography (MSCTCA). Materials and methods: In this prospective randomised controlled study, 154 patients with coronary heart disease (CHD) were classified according to body mass index (BMI) as normal weight (BMI 18–27kg/m2) or overweight (BMI ≥ 27 kg/m2), and divided into four groups: multi-modality–normal BMI group (A1, n = 82); multi-modality–overweight group (B1, n = 17); conventional–normal BMI group (A2, n = 39); and conventional–overweight group (B2, n = 16). The parameters in the multi-modality groups were as follows: isocentric scan, tube voltage = 80 kV, tube current control using 80% “smart milliampere”, and maximum current during 60–80% of the RR interval. The parameters in the conventional groups were as follows: normal position, tube voltage = 100 kV, tube current control using smart milliampere, and maximum current during 30–80% of the RR interval. The effective radiation dose (ED), objective image quality (IQ), noise, signal-to-noise ratio (SNR), contrast signal-to-noise ratio (CNR) and subjective 5-point Likert scale IQ scores of MSCTCA images were compared among the four groups. Results: The average EDs of groups A1, A2, B1and B2 were( 1.13±0.35 ) mSv, ( 3.36±1.30 ) mSv, ( 1.54±0.53 ) mSv and ( 5.90±0.93 ) mSv, respectively. There were statistically significant differences in ED between groups A1 and A2, and between groups B1 and B2 (all P < 0.01). Noise was significantly lower, and both SNR and CNR were significantly higher, in group A2 than group A1 (all P < 0.01), but there were no significant differences in these parameters between groups B1 and B2 (P = 0.14–0.51). The average IQ scores of groups A1, A2, B1and B2 were 4.46±0.59(Fig.3), 4.45±0.62(Fig.4), 4.39±0.68(Fig.5) and 4.42±0.66(Fig.6),respectively. There were no significant differences in subjective IQ scores among the four groups (P = 0.12). Consistency among observers in the subjective IQ scores of the four groups was very good, with intraclass correlation coefficients (ICCs) of 0.71–0.90. The subjective IQ scores of the coronary artery were excellent in all four groups, with a total good-to-excellent rate of ≥ 92.64%, and the total number of evaluable segments in the images of all four groups was ≥ 98.26%. Conclusions: Under conditions appropriate for clinical diagnosis, multi-modality technology can reduce the radiation dose of MSCTCA scans in both normal weight and overweight patients.

Background: Nasogastric feeding tube plays an important role in nutrition intake, drug administration, and stomach emptying for patients with severe dysphagia. However, inserting nasogastric tubes is not absolutely harmless. Inadvertent malposition into the trachea or the pleural cavity could result in severe pulmonary complications. Case presentation: We present a case of a 67-year-old patient with a history of nasopharyngeal carcinoma and after the treatment of radiotherapy and chemotherapy. Nasogastric tubes have to be placed for enteral nutrition and avoiding aspiration owing to his severe dysphagia. Unfortunately, he experienced a malposition of nasogastric tube into the right pleura cavity after blind replacement by nurse, whereas the nurses and physicians did not recognize this fault, even the bedside chest radiography (X-ray) was performed twice after intubation. A week later, his condition deteriorated so rapidly that he had to undergo tracheotomy, and the tube was finally found in his trachea.Conclusions: The Nasopharyngeal carcinoma patients after radiotherapy and chemotherapy should be fully evaluated before the nasogastric tube placement whether the blind insertion is suitable or not. Meanwhile, we should not feed immediately unless we have a radiograph to verify the right position of NG tube. Furthermore, careful monitoring of both typical and untypical symptoms of malposition is essential during tube feeding.